News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

Fred Gebhart

Articles by Fred Gebhart

Adalimumab therapy safe, effective in real-world, open-label uveitis study

ByFred Gebhart,Eric B. Suhler, MD, MPH

May 1st 2018

Latest Updated Articles

Adalimumab therapy safe, effective in real-world, open-label uveitis study
May 1st 2018

Trending on Modern Retina

Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO

Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market

NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101

FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss

Ocugen completes enrollment in liMeliGhT phase 3 trial of OCU400 for retinitis pigmentosa